Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical Industry ; with 20 TablesSpringer Science & Business Media, 2004 - 178 páginas Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. Driven by what is known the productivity dilemma in pharmaceutical innovation, many drug companies tried to hedge against risk exposure by resorting to defensive strategies such as mergers and acquisitions. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices.The authorsfocus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D. Our findings are illustrated in the case of the Swiss pharmaceutical industry, the leading exporter of pharmaceutical products in percentage of GDP, and some of its main pharmaceutical firms, such as Novartis and Hoffmann-La Roche. TOC:Challenges of Managing Pharmaceutical Innovation.- The Pharmaceutical Industry: Case Switzerland.- Technological Revolution: From Synthesis to Drug Engineering.- Strategic Management of the Drug Pipeline.- Internationalization of Pharmaceutical R&D.- Case Studies of Successful Practice.- Future Directions and Trends. |
Índice
I Innovation as a Key Success Factor in the Pharmaceutical Industry | 1 |
The Blockbuster Imperative | 5 |
Strategies for Growth | 10 |
Do You Want to Be in This Industry? | 13 |
Bargaining Power of Suppliers | 15 |
Risk of Entry from Potential Competitors | 16 |
Threat of Substitute Products | 17 |
Rivalry among Established Companies | 18 |
How to Shape the InnovationFlow | 71 |
The Complexity of Drug Discovery | 75 |
The Different Phases of the RD Process | 79 |
The RD Process at HoffmannLa Roche | 82 |
Conclusions | 85 |
How to Harness Outside Innovation | 87 |
Successful Commercialization of a Breakthrough Technology | 91 |
Trends and Drivers of Internationalization | 97 |
Differentiation via Clinical Profiles | 19 |
Entering the Market Quickly | 20 |
Conclusions | 21 |
The Case of Switzerland | 23 |
Stable Market Growth | 25 |
Sound Productivity and Employment | 30 |
Strong Support by Industry Associations | 31 |
Highly Global Orientation | 33 |
Complex Industry and Product Classification | 34 |
Fragmented Market Structure | 39 |
Conjoined Financing Systems | 43 |
Strict New Drug Registration | 44 |
Accurate Price Regulation | 50 |
How to Find New Drugs | 53 |
Fail Earlier Succeed Sooner | 58 |
Cut Experimental Cycle Times | 59 |
More than 100 Gigabyte of Data per Day | 60 |
Profiting from the Human Genome Project | 62 |
Towards Individualization and Mass Customization | 63 |
Create Tailormade Drugs | 66 |
From Experimenting to Analytic Design | 67 |
Conclusions | 68 |
RD Internationalization of Swiss Pharmaceutical Companies | 102 |
Locations of Pharmaceutical RD Abroad | 106 |
Three Principal Problems of International RD | 110 |
Conclusions | 114 |
VI Management Answers to Pharmaceutical RD Challenges | 117 |
Managing Human Resources | 119 |
Managing Projects and the Portfolio | 121 |
Managing Outsourcing Activities | 124 |
Managing Intellectual Property Rights | 127 |
Managing RD Strategy at Schering | 131 |
Managing Virtual Project Management Pools at Roche | 133 |
Managing Uncertainty at Roche | 135 |
Managing Knowhow Transfer at Kao | 136 |
Conclusions | 137 |
VII Future Directions and Trends | 139 |
VIII Appendices | 143 |
RD Management at Roche | 151 |
Bibliography | 159 |
165 | |
Glossary | 171 |
Authors | 177 |
Otras ediciones - Ver todo
Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the ... Oliver Gassmann,Gerrit Reepmeyer,Maximilian von Zedtwitz Vista previa restringida - 2013 |
Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the ... Oliver Gassmann,Gerrit Reepmeyer,Maximilian von Zedtwitz Vista previa restringida - 2008 |
Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the ... Oliver Gassmann,Gerrit Reepmeyer,Maximilian von Zedtwitz No hay ninguna vista previa disponible - 2010 |
Términos y frases comunes
Accenture AstraZeneca Basel Bayer billion biotechnology biotechnology companies blockbuster drugs blockbuster market blockbuster sales ceutical chemical clinical trials combinatorial chemistry commercialization competition compounds costs disease drug development drug discovery drug sales firms Gassmann genes genetic genomics GlaxoSmithKline Gleevec global Health healthcare Hence high-throughput screening impact important increased InnoGel international R&D Interpharma investment Japan know-how launch licensing maceutical major manufacturers market share molecular molecules Novartis oncology outsourcing overall patent protection Pfizer phar Pharma Information 2002 pharmaceutical companies pharmaceutical industry pharmaceutical innovation pharmaceutical products pharmaceutical R&D pharmaceutical research pharmaceutical-chemical industry pharmacies pharmacogenomics phase pipeline portfolio potential proteins proteomics R&D activities R&D internationalization R&D management R&D process R&D spending research and development Reuters revenues SD-physicians Serono service provider soft capsule Source strategy structure substances Swiss pharmaceutical market Swissmedic Switzerland target technical evaluation technologies therapeutic areas therapy area tion worldwide Zedtwitz
Referencias a este libro
Der Patentauslauf von Pharmazeutika als Herausforderung beim Management des ... Antje-Christina Raasch No hay ninguna vista previa disponible - 2006 |
Globalization [2 Volumes]: Encyclopedia of Trade, Labor, and Politics Ashish Vaidya No hay ninguna vista previa disponible - 2006 |